Michael Dockal Location
Vienna, Austria
Michael Dockal Work
- 2023 - now Scientific Vice President Rare Disease Research @ Novo Nordisk
- 2020 - 2023 Senior Director, Head of Rare Blood Disorders Research @ Novo Nordisk
- 2016 - 2020 Senior Director, Head of Hematology Research @ Takeda Pharmaceuticals
Michael Dockal Education
University of Natural Resources and Life Sciences, Vienna (BOKU)
Doctor of Philosophy - PhD (Biochemistry, Biotechnology)
1996 - 2000
University of Natural Resources and Life Sciences, Vienna (BOKU)
Master's degree (Biotechnology)
1990 - 1996
Michael Dockal Skills
Michael Dockal Summary
Michael Dockal, based in Vienna, Austria, is currently a Scientific Vice President Rare Disease Research at Novo Nordisk. Michael Dockal brings experience from previous roles at Novo Nordisk and Takeda. Michael Dockal holds a 1996 - 2000 Doctor of Philosophy - PhD in Biochemistry, Biotechnology @ University of Natural Resources and Life Sciences, Vienna (BOKU). With a robust skill set that includes Musik, Operational Risk and more. Michael Dockal has 3 emails on RocketReach.